Vincristine Sulfate Injection 1 mg/1 mL (9)

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

vincristine sulfate, Quantity: 1 mg/mL

Prieinama:

Pfizer (Perth) Pty Ltd

Vaisto forma:

Injection, solution

Sudėtis:

Excipient Ingredients: mannitol; sodium hydroxide; sulfuric acid; water for injections; nitrogen

Vartojimo būdas:

Intravenous Infusion, Intravenous

Vienetai pakuotėje:

5 x 1mL

Recepto tipas:

(S1) This Schedule is intentionally blank

Terapinės indikacijos:

Vincristine sulfate is indicated alone or in combination with other antitumor therapies for the treatment of: -Leukaemias, including acute lymphocytic leukaemia, chronic lymphocytic leukaemia, acute myelogenous leukaemia and blastic crisis of chronic mylogenous leukaemia -Malignant lymphomas, including Hodgkin?s disease and non-Hodgkin?s lymphomas -Lung cancer (small cell bronchogenic carcinoma) -Wilms? tumor -Neuroblastoma -Ewing?s sarcomas -True idiopathic thrombocytopenic purpura -Rhabdomyosarcoma

Produkto santrauka:

Visual Identification: clear, colourless, sterile, hypertonic, preservative-free; Container Type: Vial; Container Material: PP; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizacija statusas:

Listed (Export Only)

Leidimo data:

2023-03-14